Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
1 clinical trials · Condition
◉ Watch Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
| Record | Firm | Date |
|---|---|---|
| Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer (NCT06062563) | Peking Union Medical College Hospital | 2023-11-11 |
Track Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.